Dr. Woodrow Corey, MD

NPI: 1700844172
Total Payments
$262,512
2022 Payments
$23,899
Companies
15
Transactions
321
Medicare Patients
2,137
Medicare Billing
$145,490

Payment Breakdown by Category

Other$242,270 (92.3%)
Travel$6,999 (2.7%)
Consulting$6,888 (2.6%)
Food & Beverage$6,356 (2.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $242,270 157 92.3%
Travel and Lodging $6,999 47 2.7%
Consulting Fee $6,888 3 2.6%
Food and Beverage $6,356 114 2.4%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $91,687 103 $0 (2022)
Lilly USA, LLC $87,558 93 $0 (2022)
Amarin Pharma Inc. $41,954 43 $0 (2020)
AstraZeneca Pharmaceuticals LP $40,462 53 $0 (2021)
Janssen Pharmaceuticals, Inc $259.27 9 $0 (2021)
Novo Nordisk Inc $152.06 3 $0 (2021)
Janssen Scientific Affairs, LLC $122.57 1 $0 (2019)
Novartis Pharmaceuticals Corporation $109.61 2 $0 (2021)
SANOFI-AVENTIS U.S. LLC $62.77 4 $0 (2019)
PFIZER INC. $38.58 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $23,899 23 Boehringer Ingelheim Pharmaceuticals, Inc. ($16,619)
2021 $66,153 75 Boehringer Ingelheim Pharmaceuticals, Inc. ($30,004)
2020 $90,745 103 Lilly USA, LLC ($39,861)
2019 $81,511 113 Boehringer Ingelheim Pharmaceuticals, Inc. ($35,600)
2018 $204.17 7 Boehringer Ingelheim Pharmaceuticals, Inc. ($121.36)

All Payment Transactions

321 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
09/29/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
08/19/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
07/12/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $520.00 General
Category: Diabetes
06/03/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
05/05/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $167.31 General
Category: DIABETES
05/05/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $18.72 General
Category: DIABETES
05/04/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,375.00 General
Category: DIABETES
05/04/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,375.00 General
Category: DIABETES
05/04/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
05/04/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Travel and Lodging In-kind items and services $170.82 General
Category: DIABETES
04/27/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $79.70 General
Category: DIABETES
04/21/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,850.00 General
Category: DIABETES
04/20/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $102.40 General
Category: DIABETES
04/18/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
04/13/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $119.97 General
Category: DIABETES
04/13/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $119.97 General
Category: DIABETES
04/04/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,560.00 General
Category: Diabetes
03/30/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
03/29/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
03/25/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: DIABETES
03/25/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
03/04/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
02/18/2022 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,040.00 General
Category: Diabetes
12/20/2021 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,550.00 General
Category: DIABETES
12/09/2021 Lilly USA, LLC JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 7 587 701 $121,703 $40,227
2021 10 793 989 $186,456 $63,525
2020 10 757 849 $160,389 $41,737
Total Patients
2,137
Total Services
2,539
Medicare Billing
$145,490
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 265 346 $58,820 $26,671 45.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 60 60 $16,200 $6,429 39.7%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2022 12 12 $13,080 $1,582 12.1%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Facility 2022 25 25 $12,645 $1,313 10.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 114 124 $10,788 $1,214 11.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 19 19 $2,280 $1,100 48.3%
83036 Hemoglobin a1c level Office 2022 81 104 $6,240 $1,000 16.0%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 11 11 $1,650 $918.52 55.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 301 467 $79,390 $41,834 52.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 80 80 $21,600 $9,144 42.3%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 20 20 $21,160 $2,850 13.5%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Facility 2021 54 54 $26,295 $2,775 10.6%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 203 228 $19,836 $2,329 11.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 13 13 $2,990 $1,810 60.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 52 54 $6,480 $1,717 26.5%
93350 Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report Facility 2021 13 13 $4,615 $608.19 13.2%
83036 Hemoglobin a1c level Office 2021 29 30 $1,800 $281.59 15.6%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Facility 2021 13 13 $1,950 $125.73 6.4%
36415 Insertion of needle into vein for collection of blood sample Office 2021 15 17 $340.00 $51.00 15.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 154 185 $31,450 $14,212 45.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 183 225 $27,000 $9,132 33.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 50 50 $13,500 $5,706 42.3%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Facility 2020 76 76 $35,508 $3,844 10.8%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2020 27 27 $28,150 $3,808 13.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 159 173 $15,051 $1,893 12.6%

About Dr. Woodrow Corey, MD

Dr. Woodrow Corey, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700844172.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Woodrow Corey, MD has received a total of $262,512 in payments from pharmaceutical and medical device companies, with $23,899 received in 2022. These payments were reported across 321 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($242,270).

As a Medicare-enrolled provider, Corey has provided services to 2,137 Medicare beneficiaries, totaling 2,539 services with total Medicare billing of $145,490. Data is available for 3 years (2020–2022), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Cardiovascular Disease, Interventional Cardiology
  • Location Indianapolis, IN
  • Active Since 05/03/2006
  • Last Updated 08/11/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1700844172

Products in Payments

  • JARDIANCE (Drug) $168,778
  • Vascepa (Drug) $41,954
  • FARXIGA (Drug) $40,399
  • TRULICITY (Drug) $6,413
  • INVOKANA (Drug) $224.17
  • XARELTO (Drug) $157.67
  • LEQVIO (Drug) $96.34
  • PRALUENT (Drug) $49.03
  • BRILINTA (Drug) $44.18
  • CHANTIX (Drug) $38.58
  • LifeVest (Device) $19.00
  • Repatha (Biological) $17.29
  • PRADAXA (Drug) $16.90
  • PRALUENT (Biological) $16.89
  • Corlanor (Drug) $14.89
  • ELIQUIS (Drug) $13.74
  • MULTAQ (Drug) $13.74
  • ENTRESTO (Drug) $13.27
  • Ozempic (Drug) $12.34
  • PRALUENT ALIROCUMAB INJECTION (Biological) $12.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Indianapolis